Gastrointestinal Barrier Breakdown and Adipose Tissue Inflammation

Area of Science:

• Gastroenterology
• Metabolic Health
• Immunology

Background:

• Obesity is characterized by chronic inflammation.
• The intestinal barrier and microbiome are crucial for metabolic homeostasis.
• Dysfunction in these systems contributes to systemic inflammation.

Purpose of the Study:

• To review current evidence on the role of the intestinal barrier and microbiome in obesity-related adipose tissue inflammation.
• To explore metabolic factors influencing intestinal barrier integrity.

Main Methods:

• Literature review of recent scientific data.
• Synthesis of findings on gut barrier function, microbiome, and inflammation.
• Analysis of metabolic influences on the intestinal barrier.

Main Results:

• Obesity and metabolic diseases like diabetes mellitus are linked to impaired intestinal barrier function.
• Intestinal microbiota and diet are vital for maintaining gut epithelial health.
• Intestinal barrier dysfunction exacerbates inflammation, potentially damaging tight junction proteins and worsening adipose tissue inflammation across various conditions (obesity, diabetes, HIV, IBD).

Conclusions:

• Intestinal barrier breakdown is a significant factor in adipose tissue inflammation in obesity and other chronic diseases.
• Targeting intestinal barrier function presents a potential therapeutic strategy for reducing inflammation in obesity and related conditions.
• Restoring intestinal barrier integrity may mitigate chronic inflammatory states.